Loading clinical trials...

Comparison of Deferasirox and Desferoxamine in Patients of β-Thalassemia Major With Iron Overload | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT06468423

Comparison of Deferasirox and Desferoxamine in Patients of β-Thalassemia Major With Iron Overload

This study was planned to compare deferasirox and desferrioxamine in terms of mean serum ferritin levels in patients of β-thalassemia major having Iron overload. Choosing an effective iron chelator is...

Lead sponsor: RESnTEC, Institute of Research•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment142

Start dateJan 2023

Last updatedJun 21, 2024

Condition

Pateints of β-thalassemia Major With Iron Overload

Locations shown

Thalassemia Center of Hematology Department, The Children's Hospital & The Institute of Child Health

Multan, Punjab Province

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 21, 2024Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions